Pulse Biosciences (PLSE) Other financing activities (2016 - 2024)

Pulse Biosciences (PLSE) recorded quarterly Other financing activities of $59000.0 in Q4 2024, up 205.36% quarter-over-quarter from -$56000.0 in Q3 2024, and up 1083.33% on a YoY basis from $4985.9 in Q1 2024.

Pulse Biosciences (PLSE) Other financing activities (2016 - 2024) Analysis & Trends

Pulse Biosciences' Other financing activities history runs 5 years deep, the most recent figure standing at $59000.0 for Q4 2024.

  • In Q4 2024, Other financing activities rose 1083.33% year-over-year to $59000.0; the TTM figure through Dec 2025 stood at $3000.0 (changed 0.0% YoY), while the FY2024 annual figure was $281000.0, changed N/A from the prior year.
  • Other financing activities was $59000.0 for Q4 2024 at Pulse Biosciences, up from -$56000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $59000.0 in Q4 2024 to a low of -$56000.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn
10 Pulse Biosciences 1.68 Bn 1.68 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2024 59,000.00
Dec 31, 2024 59,000.00
Sep 30, 2024 -56,000.00
Sep 30, 2024 -56,000.00
Dec 31, 2023 -6,000.00
Dec 31, 2023 -6,000.00
Sep 30, 2023 6,000.00
Sep 30, 2023 6,000.00
Mar 31, 2019 222,000.00
Mar 31, 2019 222,000.00
Mar 31, 2018 188,000.00
Mar 31, 2018 188,000.00
Sep 30, 2016 67,000.00
Sep 30, 2016 67,000.00